Lymph node ratio as a predictor of survival in gastric carcinoma

American Surgeon

Volumn 79, Issue 3, 2013, Pages 284-289

  Medina Franco, Heriberto ^a   Cabrera Mendoza, Francisco ^a   Almaguer Rosales, Susana ^a   Guillén, Fabiola ^a   Suárez Bobadilla, Yoli L ^a   Sánchez Ramón, Ariadne ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STOMACH CARCINOMA; SURVIVAL PREDICTION; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEXICO; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84876151236     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hogenberger O, Gretschel S. Gastric cancer. Lancet 2003;362:305-15. (Pubitemid 36936845)
2. Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005;241:27-39. (Pubitemid 40044837)
3. Katai H, Yoshimura K, Maruyama K, et al. Evaluation of the new International Union Against Cancer TNM staging for gastric carcinoma. Cancer 2000;88:1796-800. (Pubitemid 30212987)
4. Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9:775-84.
5. Shen JY, Kim S, Cheong JH, et al. The impact of total retrieved nodes on staging and survival of patients with pT3 gastric cancer. Cancer 2007;110:745-51.
6. deManzoni G, Verlato G, Guglielmi A, et al. Classification of lymph nodes metastases in the carcinoma of the stomach: comparison between the old and the new TNM systems. World J Surg 1999;23:664-9.
7. Al-Refaie WB, Gay G, Virnig BA, et al. Variation in gastric cancer care: a trend beyond racial disparities. Cancer 2010;116:465-75.
8. Marchet A, Mocellin S, Ambrosi A, Morgagni P. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy. Results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-52. (Pubitemid 46555657)
9. Sianesi M, Bezer L, Del Rio P, et al. The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg 2010;14:614-9.
10. Kim CY, Yang DH. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol 2009;16:1868-74.
11. Celen O, Yildirim E, Berberoglu Y. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol 2007;96:95-101. (Pubitemid 47264811)
12. Pedrazzani C, Sivins A, Ancans G, et al. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy. Results from a single-center experience of 526 patients. World J Surg 2010;34:85-91.
13. Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003;10:1077-85. (Pubitemid 40486832)
14. th ed. New York, NY: Springer; 2002.
15. McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph node dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004;1:CD001964.
16. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004;22:2069-77.
17. Kulig J, Popiela T, Kolodziejczyk P, et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007;193:10-5. (Pubitemid 44937167)
18. Liu C, Lu P, Lu Y, et al. Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer 2007;7:200.
19. Bunt AM, Hermans J, Smith VT, et al. Surgical/pathologicstage migration confronts comparisons of gastric cancer survival rate between Japan and Western countries. J Clin Oncol 1995;13:19-25.
20. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol 2010;11:439-49.
21. th ed. New York, NY: Springer; 2010.
22. Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002;9:27-34. (Pubitemid 34262894)
23. Cheong JH, Hyung WJ, Shen JG, et al. The N ratio predict recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol 2006;13:377-85.
24. Deng J, Liang H, Wang D, et al. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol 2010;17:1043-51.
25. Kong SH, Lee HJ, Ahn HS, et al. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy. Ann Surg 2012;255:50-8.
26. th AJCC system for gastric cancer. Ann Surg 2012;255:478-85.